Concepedia

A phase Ib trial with MK-8628/OTX015, a small molecule inhibitor of bromodomain (BRD) and extra-terminal (BET) proteins, in patients with selected advanced solid tumors

C. Massard, Jean‐Charles Soria, Anastasios Stathis, Jean‐Pierre Delord, Ahmad Awada, S. Peters, Jeremy Lewin, M. Bekradda, Keyvan Rezaï, Zhi Zeng,

European Journal of Cancer · 2016 · 30 citations · 0 references

Concepts

MedicineOncologyPharmacologyCancer PharmacologyImmunotherapyMolecular OncologyCancer ImmunotherapyImmunotherapy For Solid TumorsSolid Tumor OncologyTargeted Cancer TherapyTargeted TherapyTumor BiologyBromodomain InhibitionBromodomain Protein TargetingBromodomain ProteinsMolecularly Targeted Therapy Trials